The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia rose from 83.7% for 1990-1994 to 90.4% for 2000-2005.
Gene expression profiling has demonstrated that appendiceal cancer is quite distinct from colorectal cancer and may require different treatment.
Advanced profiling of gene mutations in acute myeloid leukemia could potentially be used to help predict prognosis and guide treatment decisions.
New 64 gene-based classifier detects BRAF mutant tumors and subgroup with poor prognosis
A newly identified subtype of ovarian cancer that builds its own blood vessels may be vulnerable to agents that block blood vessel formation.
Investigators have discovered why the pill Zelboraf (vemurafenib), effective against melanoma, may also cause the development of a secondary skin cancer: squamous cell carcinoma.
Researchers have discovered a rare but recurrent mutation that increases the risk of hereditary prostate cancer by up to 20 times.
Parents are more likely than not to tell their sons and daughters younger than 25 years whether or not the parent carries inheritable mutations in BRCA1 or BRCA2 genes.
Mutations in the ATM gene may raise a person’s hereditary risk for pancreatic cancer, information that could lead to better screening methods for the disease.